Showing 1 - 3 results of 3 for search 'Jian-zhou Cao', query time: 0.03s Refine Results
  1. 1
    Case Report: Anlotinib Combined With Sintilimab as Third-Line Treatment in a Metastatic Urothelial Bladder Carcinoma Patient With FGFR3 Mutation

    Case Report: Anlotinib Combined With Sintilimab as Third-Line Treatment in a Metastatic Urothelial Bladder Carcinoma Patient With FGFR3 Mutation by Jian-zhou Cao, Jian-zhou Cao, Wei Wu, Jin-feng Pan, Jin-feng Pan, Hong-wei Wang, Jun-hui Jiang, Jun-hui Jiang, Qi Ma, Qi Ma, Qi Ma, Qi Ma

    Published 2021-05-01
    Get full text
    Article
  2. 2
    The Use of High-Intensity Focused Ultrasound (HIFU) Plus 150mg Bicalutamide as First Line Salvage Therapy for Local Recurrent Prostate Cancer

    The Use of High-Intensity Focused Ultrasound (HIFU) Plus 150mg Bicalutamide as First Line Salvage Therapy for Local Recurrent Prostate Cancer by Jian-zhou Cao, Jian-zhou Cao, Rui Su, Rui Su, Rui Su, Jin-feng Pan, Jin-feng Pan, Ze-jun Yan, Ze-jun Yan, Qi Ma, Qi Ma, Qi Ma, Qi Ma

    Published 2021-11-01
    Get full text
    Article
  3. 3
    Case report: Complete response of a bladder cancer patient with multiple hepatic and pelvic metastases treated by nab-paclitaxel combined with sintilimab

    Case report: Complete response of a bladder cancer patient with multiple hepatic and pelvic metastases treated by nab-paclitaxel combined with sintilimab by Zhu-lei Tao, Zhu-lei Tao, Wei Wu, Lin-chun Liang, Jin-feng Pan, Jin-feng Pan, Jian-zhou Cao, Jian-zhou Cao, Xiao-long Jia, Xiao-long Jia, Li Fang, Li Fang, Qi Ma, Qi Ma, Qi Ma, Qi Ma

    Published 2022-12-01
    Get full text
    Article

Search Tools: